The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
Open accessAbstract
Emerging evidence supports a key role for the gut microbiota in metabolic diseases, including type 2 diabetes (T2D) and obesity. The dipeptidyl peptidase-4 inhibitor vildagliptin is highly efficacious in treating T2D. However, whether vildagliptin can alter the gut microbiome is still unclear. This study aimed to identify whether vildagliptin modifies the gut microbiota structure during T2D treatment. Diabetic Sprague-Dawley (SD) rats were induced by a high-fat diet and streptozotocin injection (HFD/STZ). Diabetic rats were orally administered a low dose of vildagliptin (LV, 0.01 g/kg/d vildagliptin), high dose of vildagliptin (HV, 0.02 g/kg/d vildagliptin), or normal saline for 12 weeks. Fasting blood glucose, blood glucose after glucose loading, and serum insulin levels were significantly reduced in the LV and HV groups compared with those in the T2D group. The serum GLP-1 level increased more in the vildagliptin-treated group than in the T2D group. Pyrosequencing of the V3-V4 regions of 16S rRNA genes revealed that vildagliptin significantly altered the gut microbiota. The operational taxonomic units (OTUs) and community richness (Chao1) index were significantly reduced in the vildagliptin and diabetic groups compared with those in the control group. At the phylum level, a higher relative abundance of Bacteroidetes, lower abundance of Firmicutes, and reduced ratio of Fimicutes/Bacteroidetes were observed in the vildagliptin-treated group. Moreover, vildagliptin treatment increased butyrate-producing bacteria, including Baceroides and Erysipelotrichaeae, in the diabetic rats. Moreover, Lachnospira abundance was significantly negatively correlated with fasting blood glucose levels. In conclusion, vildagliptin treatment could benefit the communities of the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, vildagliptin reduces Firmicutes to Bacteroidetes ratio, increases Lactobacilli spp. and increases propionate production [308].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [308]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cited by
Items 101–124 of 124
Fu, X., Xie, Y., Xie, Y., Han, A., Zhou, X., Zhang, S., Shen, C., Zhang, Y., Wang, L., & Xie, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1860661 · Cited by 1
“…Smits et al. reported in a study using DPP-4is as adjunctive therapy for diabetic patients, that no signi fi cant changes in fecal microbiota were observed after 12 weeks of treatment (49), which differs from the results of gut microbiota alterations observed in multiple animal studies (48, 50).”
Age-Related Changes in the Gut Microbiota Composition of Hog Deer (Axis porcinus)
Yan, H.-J., Wang, W., Yu, J., Yi, J., Niu, L., Chen, H., Qu, Y., Pu, Y., Chen, A., Zhong, Y., et al. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20190729100714 · Cited by 3
Gut Microbiota and Its Role in Human Metabolic Disorders
Yadav, A., Mohite, S. V., Behl, A., Shinde, P. B., & Sharma, K. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-3126-2_14 · Cited by 1
Ураков, А. Л., Гуревич, К. Г., Sorokina, Y. А., Ловцова, Л. В., Занозина, О. В., & Анатольевич, М. А. (2018) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf1625-12 · Cited by 1
“При ожирении наблюдается превалирование Firmicutes и общее обеднение бутират-продуцирующей микробиоты, что клинически значимо коррегировалось применением вилдаглиптина [48].”
Implications of microbiota in the pathogenesis of diabetes mellitus and cardiovascular disease
Tănase, D. M., Leustean, A. M., & Gosav, E. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00005-8
Kumar, S., Saini, V., & Raj, V. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.22.461387
“The abundance of Oscillospira positively correlates with fasting serum insulin and reduction in Zonula occludens-1 (ZO-1) mRNA expression indicates their potential role in developing obesity-related metabolic disorders and gut dysfunction [14,15].”
BackgroundStudy on Diabetic Rats Comparing the Effects of Sitagliptin and Probiotics on Serum Glucose
Lateef, N., Rehman, I., Tahir, M., Tahir, M. N., ., A., & Memon, F. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221651135
Diabetes Mellitus and Microbiota: Knowledge and Perspectives
Rizzo, G. E., Rizzi, A., Tartaglione, L., Leo, M. L., Viti, L., Leo, M. A. S. D., & Pitocco, D. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_7 · Cited by 1
Xia, Y., Lee, G., Takei, N., Takahashi, H., & Kuda, T. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08237-9
Chen, C.-H., & Ding, L.-X. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20221011021005
Liu, Y., Wang, S., & Yang, T. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20230330030335
Analgesic Effect of Nalbuphine Combined with Sufentanil After Laparoscopic Hysterectomy
Cai, Z., Jiang, X., Dai, X., & Wu, P. (2023) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20230331210308
“These 2 genera were positively related with fasting insulin and a decrease of blood glucose (Zhang et al., 2017).”
BackgroundKumar, S., Pandey, R. P., Chang, C.-M., & Raj, V. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3341945/v1
Guardado‐Mendoza, R., Martínez-López, Y. E., Neri-Rosario, D., Esquivel-Hernandez, D. A., Padrón-Manrique, C., Vázquez-Jiménez, A., Sánchez-Castañeda, J. P., Giron-Villalobos, D., Mendoza-Ortíz, C., Reyes‐Escogido, M. D. L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3378211/v1
Huang, Q., Yang, L., Cai, G., Huang, Y., Zhang, S., Ye, Z., Yang, J., Gao, C., Lai, J., Lin, L., et al. (2023) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1292273
Sinyushkina, S. D., Gorinova, A. V., Belousova, A. S., Sorokina, Y. А., & Занозина, О. В. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-386
Microbiota intestinale e farmaci ipoglicemizzanti: la comunicazione che cura
Rubino, M., Cassano, V., & Hribal, M. L. (2025) · il Diabete · doi:10.30682/ildia2501c
Gut Microbiota in Type 2 Diabetes
Ganguly, A., & Patra, F. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324549125010008
Zhen, J., Sun, Y., Zhao, P., Li, C., Wang, H., Li, Y., Zhao, L., Wang, L., Huang, G., & Xu, A. (2021) · Figshare · doi:10.6084/m9.figshare.14703935
Zhen, J., Sun, Y., Zhao, P., Li, C., Wang, H., Li, Y., Zhao, L., Wang, L., Huang, G., & Xu, A. (2021) · Figshare · doi:10.6084/m9.figshare.14703932
Dinu, L.-D., Vamanu, E., & Avram, I. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_7
The gut microbiome and metabolic health in aging
Sharma, S., & Gautam, G. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44665-8.00003-1
Modulatory effects of culinary spices on the human gut microbiome in type II diabetes management
Chuphal, B., Kumari, M., & Kumar, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44546-0.00003-7
Eid, A. M., EL-Gendy, A. O., & Ewees, M. G. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05961-y
Metadata
- Authors
- Zhang, Q., Xiao, X., Li, M., Yu, M., Ping, F., Zheng, J., Wang, T., & Wang, X.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Xiao, Xinhua
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-10-16
- Volume
- 12
- Issue
- 10
- Pages
- e0184735
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5643055
- OpenAlex
- W2765808908
- Cited by
- 124
- References
- 56
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 11 · 2023: 26 · 2022: 21 · 2021: 15 · 2020: 14 · 2019: 11 · 2018: 6
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Key Research and Development Program of China (2016YFA0101002)
- National Natural Science Foundation of China (81170736, 81570715)
- National Natural Science Foundation for Young Scholars of China (81300649)
- China Scholarship Council Foundation (201308110443)
- PUMC Youth Fund (33320140022)
- China Diabetes Young Scientific Talent Research Funding
- Diabetes Research Fund from Clinical Research of Chinese Medical Association and Chinese Diabetes Society (12030500350)
- Fundamental Research Funds for the Central Universities
- the Scientific Activities Foundation for Selected Returned Overseas Professional of Human Resources and Social Security Ministry
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- vildagliptin, type 2 diabetes, gut microbiota, butyrate-producing bacteria, DPP-4 inhibitors, high-fat diet and streptozotocin-induced diabetes, glucagon-like peptide-1, Firmicutes/Bacteroidetes ratio, Bacteroides, Lachnospira, fasting blood glucose, insulin
- MeSH terms
- Gastrointestinal Microbiome, Vildagliptin, Adamantane, Administration, Oral, Animals, Blood Glucose, Butyrates, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Insulin Resistance, Male, Nitriles, Pyrrolidines, Random Allocation, RNA, Ribosomal, 16S, Interleukin-6, Rats, Sprague-Dawley, Glucagon-Like Peptide 1, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.